3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with homovanillic acid in 5 studies
| Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Studies (homovanillic acid) | Trials (homovanillic acid) | Recent Studies (post-2010) (homovanillic acid) |
|---|---|---|---|---|---|
| 330 | 40 | 33 | 6,127 | 312 | 438 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abi-Dargham, A; Baldwin, RM; Bowers, MB; Charney, DS; D'Souza, CD; Fingado, CL; Innis, RB; Jatlow, P; Kanes, SJ; Laruelle, M; Seibyl, JP; Zoghbi, SS | 1 |
| Anderson, GM; Baldwin, RM; Fujita, M; Innis, RB; Jatlow, PA; Seibyl, JP; Varrone, A; Verhoeff, NP; Zoghbi, SS | 1 |
| Abdo, WF; Bloem, BR; De Jong, D; Hendriks, JC; Horstink, MW; Kremer, BP; Verbeek, MM | 1 |
| Angerer, A; Antke, C; Arendt, G; Carey, P; Husstedt, IW; Koutsilieri, E; Maschke, M; Meisner, F; Müller, HW; Neuen-Jacob, E; Nolting, T; Obermann, M; Riederer, P; Scheller, C; Sopper, S; Ter Meulen, V | 1 |
| Bloemen, OJ; Booij, J; de Haan, L; de Koning, MB; Gleich, T; Linszen, DH; Meijer, J; van Amelsvoort, TA | 1 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and homovanillic acid
| Article | Year |
|---|---|
Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis.
Topics: Adult; alpha-Methyltyrosine; Benzamides; Case-Control Studies; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Female; Functional Neuroimaging; Homovanillic Acid; Humans; Male; Prolactin; Psychotic Disorders; Pyrrolidines; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Tyrosine 3-Monooxygenase | 2013 |
4 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and homovanillic acid
| Article | Year |
|---|---|
Imaging D2 receptor occupancy by endogenous dopamine in humans.
Topics: Adult; Affect; alpha-Methyltyrosine; Animals; Benzamides; Brain; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Humans; Iodine Radioisotopes; Male; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tyrosine 3-Monooxygenase | 1997 |
Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humans.
Topics: Adult; alpha-Methyltyrosine; Benzamides; Brain Chemistry; Dopamine; Female; Homovanillic Acid; Humans; Iodine Radioisotopes; Lorazepam; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 2000 |
Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease.
Topics: Adult; Aged; Benzamides; Brain; Diagnosis, Differential; Electromyography; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Iodine Radioisotopes; Lactic Acid; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; NAD; Parkinson Disease; Pyrrolidines; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2004 |
Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Case-Control Studies; CD4 Antigens; Chemokine CCL2; Dopamine; Galactosephosphates; HIV; HIV Infections; Homovanillic Acid; Humans; Male; Middle Aged; Pyrrolidines; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon; Tropanes; Viral Load | 2010 |